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Abstract To assess in a multicenter design the
between-center reproducibility of volumetric virtual
histology intravascular ultrasound (VH-IVUS) mea-
surements with a semi-automated, computer-assisted
contour detection system in coronary lesions that were
consecutively stented. To evaluate the reproducibility
of volumetric VH-IVUS measurements, experienced
analysts of 4 European IVUS centers performed
independent analyses (in total 8,052 cross-sectional
analyses) to obtain volumetric data of 40 coronary
segments (length 20.0 ± 0.3 mm) from target lesions
prior to percutaneous intervention that were per-
formed in the setting of stable (65%) or unstable
angina pectoris (35%). Geometric and compositional
VH-IVUS measurements were highly correlated for
the different comparisons. Overall intraclass correla-
tion for vessel, lumen, plaque volume and plaque
burden was 0.99, 0.92, 0.96, and 0.83, respectively; for
fibrous, fibro-lipidic, necrotic core and calcified vol-
umes overall intraclass correlation was 0.96, 0.94,
0.98, and 0.99, respectively. Nevertheless, significant
differences for both geometrical and compositional
measurements were seen. Of the plaque components,
fibrous tissue and necrotic core showed on average the
highest measurement reproducibility. A central anal-
ysis for VH-IVUS multicenter studies of lesions prior
to PCI should be pursued. Moreover, it may be
problematical to pool VH-IVUS data of individual
trials analyzed by independent centers.
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Introduction
Virtual Histology intravascular ultrasound (VH-
IVUS) allows measurements of both atherosclerotic
plaque and vessel size and plaque composition in vivo
[1–10]. Plaque composition of target lesions prior to
percutaneous coronary intervention (PCI) may impact
clinical outcome following PCI [11–19]. A relatively
large necrotic core volume in target lesions as assessed
with VH-IVUS is an independent predictor of creatine
kinase and troponin elevation after PCI [11, 15].
Microembolization of such plaque components may
lead to myocardial injury during stent implantation
[11, 14, 16, 18, 20]. Certain plaque components or
phenotypes as assessed with VH-IVUS are related to
no-reflow phenomenon post-PCI which may be trig-
gered by such microembolization and adversely
affects prognosis [14, 18]. Therefore, volumetric
VH-IVUS assessment of target lesions prior to PCI
may have the potential to identify lesions at particu-
larly high risk for such complications and may help to
tailor such procedures. However, an important pre-
requisite for clinical VH-IVUS studies assessing such
relations in advanced coronary lesions prior to PCI is
an adequate measurement reproducibility [2].
We recently reported significant but small differ-
ences for VH-IVUS measurements of mild-to-moder-
ately diseased coronary segments between different
European IVUS centers [21]. But so far, no data is
available on the between-center reproducibility of
VH-IVUS measurements of advanced lesions prior to
PCI. Therefore, in the present study we assessed
the between-center reproducibility of volumetric
VH-IVUS measurements of target lesions, that were
consecutively stented, by comparing data from
repeated analyses as performed by independent
analysts at 4 independent IVUS centers in Europe.
Methods
Study population
In order to assess the between-center reproducibility of
segmental volumetric VH-IVUS data analysis of dis-
eased atherosclerotic human coronary arteries, we
performed IVUS analyses in 20 mm-long segments of
coronary lesions prior to PCI in patients with unstable
angina pectoris or stable angina. Coronary segments had
to meet the following inclusion criteria: no severe plaque
calcification, no major vessel tortuosity, and/or major
side-branches. In this multicenter study design, 4
experienced analysts independently performed VH-
IVUS analyses of all segments included in the study.
Each IVUS center was invited to submit IVUS pullbacks
of 10 coronary segments obtained from patients in sinus
rhythm in whom a clinically driven cardiac catheterization
required IVUS assessment prior to PCI. Participating
centers were Odense University Hospital, Odense,
Denmark; Essen University Hospital, Essen, Germany;
Central University Hospital, Warsaw, Poland; and
Thoraxcentrum Twente, Enschede, The Netherlands.
IVUS data acquisition
Acquisition of IVUS data was performed in an
ECG-gated way with commercially available phased-
array IVUS catheters (Eagle Eye Gold 2.9F 20 MHz,
Volcano Corporation, Rancho Cordova, CA, USA) with
a dedicated console [22]. The IVUS transducer was
advanced C10 mm distal to the most distal side-branch.
Angiographic cine runs were performed to define the
position of the IVUS transducer. After intracoronary
injection of 200 lg nitroglycerin, a continuous pullback
of the IVUS catheter was performed using a motorized
pullback device at 0.5 mm/s (TrackBack-II, Volcano
Corporation). IVUS image data were stored on digital
video disk (DVD) for offline analysis.
VH-IVUS data analysis
Description of the technique and the validation of
VH-IVUS have previously been published [1, 3, 4, 6].
In brief, tissue maps are reconstructed from spectral
IVUS radiofrequency data and classify the plaque in
four major components: calcium, fibro-lipidic, fibrous,
and necrotic core. Tissue components were displayed
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according to a color code (white, light-green, green,
and red, respectively).
Offline VH-IVUS analysis of all cases was per-
formed by one experienced IVUS analyst per center
(Fig. 1). The IVUS sequences were provided with a
predefined region of interest (20 mm length) that
contained a (part of a) target lesion for PCI. Segments
were located between two adjacent side-branches and
contained no major calcification that could have limited
reliable detection of the external vascular boundary.
By use of the VH-images and software, IVUS mea-
surements of geometry and plaque composition were
made. The lumen and vessel borders were traced using a
semi-automated, computer-assisted contour detection
program (Volcano pcVH software program version 2.2;
Volcano); to exclude potential between version differ-
ences of the analysis software, all four centers used the
latest version of the analysis software. The leading edge
of the blood-intima acoustic interface and the leading
edge of the media-adventitia interface were automati-
cally detected to define the lumen and vessel borders,
respectively, and manually corrected as required.
Plaque & media was used as a measure of atheroscle-
rotic plaque and was calculated as the difference
between vessel and lumen cross-sectional area. For
each coronary segment, volumetric data of the vessel,
lumen, plaque and plaque burden, as well as fibrous,
fibro-lipidic, necrotic core, and calcified tissue were
obtained from the application of the trapezium method
to the cross-sectional area measurements [21, 23]. The
pcVH software program uses this method that considers
the exact spacing between image frames to calculate
volumes from the cross-sectional area data in the most
accurate way. In addition, the relative amount of the
four plaque components was calculated. To account for
any differences in length, all volumetric data were
normalized for 10 mm-long segments [21, 23].
In order to assess the between-center reproducibil-
ity of volumetric VH-IVUS analyses, comparisons
were performed on a two-observer basis (i.e., center A
vs. B, C and D respectively; center B vs. C and D
respectively; and center C vs. D).
Statistical analysis
Statistical analysis was performed with SPSS 15.0
(SPSS Inc., Chicago, IL, USA). Dichotomous vari-
ables are presented as frequencies, while quantitative
data are presented as mean ± 1SD (or ±1SEM).
Quantitative data were compared by use of a paired
t test after Normality of the data was confirmed. A
two-sided P-value \ 0.05 was considered as signifi-
cant. According to Bland and Altman, the agreement
between two measurements was assessed by deter-
mining the mean ± 2SD of the between measurement
differences [24]. Intra-class correlations were calculated
for comparisons at an individual level. An intra-class
correlation[0.90 was considered good.
Results
Study population
A total of 40 coronary segments (6 right; 27 left
anterior descending; and 7 left circumflex coronary
Fig. 1 Image acquisition and data analysis. Motorized pull-
backs at 0.5 mm/s (including image frame acquisition at the
time of the R-wave peak) were performed by each IVUS center
(A–D). These pullback sequences (obtained from 10 patients)
were exchanged in order to obtain a ‘pullback pool’ of 40
pullbacks, which each analyst independently analyzed (I).
Automated contour detection and, if required, manual correction
of the lumen and vessel border were performed on all frames
using the VH-images and software (II). Volumetric VH-IVUS
data of vessel and plaque geometry and plaque composition
were automatically generated for the analyzed segment based on
the application of Trapezium method (III)
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arteries) were analyzed from 40 patients (age
64 ± 10 years, 75% were male) who were in sinus
rhythm during the IVUS pullback. IVUS examination
was performed in both patients with stable syndromes
(65%) and unstable syndromes (35%). Eighty-eight
percent of the patients was on statin therapy prior to
the cardiac catheterization, and 35% was diabetics.
There was no complication related to IVUS imaging.
VH-IVUS analysis and data
Independent analysis of each of the 40 coronary
segments was performed by each of the four analysts
and volumetric data was obtained to evaluate the
reproducibility of volumetric VH-IVUS measure-
ments (50 ± 14 frames/segment). This approach
required the analysis of a total of 8,052 cross-sectional
frames (2,013 frames per analyst). Manual correction
of the automatic border detection was required in
almost all frames for a total analysis time of 60 ±
6 min/segment. The length of the analyzed segments
was 20.0 ± 0.3 mm (range: 19.1–20.6 mm). On aver-
age, the atherosclerotic segments contained predom-
inantly fibrous (57.4%), fibro-lipidic (13.1%), and
necrotic core (19.1%) tissue. Geometric and compo-
sitional IVUS data obtained by the analysts of the 4
different centers (A–D) are presented in Table 1.
VH-IVUS measurement variability of plaque
and vessel geometry
VH-IVUS measurements of vessel geometry were
highly correlated for the different comparisons. Over-
all intra-class correlation and range of the individual
between-center comparisons (within brackets) was for
vessel, lumen, plaque volume and plaque burden 0.99
(0.98–1.00), 0.92 (0.84–0.97), 0.96 (0.93–0.98), and
0.83 (0.75–0.90), respectively. Although there were
significant differences for vessel, lumen, and plaque
volumes, these differences were only moderate in size
(Tables 1, 2; Fig. 2). Plaque burden also showed
significant differences for the comparisons between
two centers. However, the differences were only
moderate in size, ranging from 0.8 to 4.6%. Statistical
analysis using Anova with Holm-Bonferroni correc-
tion did not show significant differences, except for
plaque burden measurements of center C versus D
(adjusted P-value 0.048), no significant differences
were seen (P [ 0.1, Table 1). The limits of agreement
(i.e., 2 SD of mean difference) were relatively small
and similar for the different comparisons; measure-
ment reproducibility of vessel volume was particu-
larly high (Fig. 3a, b). Measurement reproducibility
was not influenced by the size of the measured
volumes.
Table 1 VH-IVUS data from four different centers (A–D)
A B C D ANOVA
Vessel geometrics
Vessel volume (mm3) 162.8 ± 36.3 156.9 ± 37.7 163.1 ± 36.7 159.4 ± 36.4 0.9
Lumen volume (mm3) 73.8 ± 16.5 74.3 ± 17.3 78.9 ± 18.6 69.8 ± 17.1 0.2
Plaque volume (mm3) 89.0 ± 25.7 82.6 ± 26.9 84.3 ± 25.0 89.5 ± 26.1 0.7
Plaque burden (%) 54.2 ± 6.8 52.0 ± 7.7 51.3 ± 7.6 55.8 ± 7.5 0.051*
Plaque composition
Fibrous volume (mm3) 31.0 ± 16.1 27.9 ± 16.1 28.1 ± 14.9 31.7 ± 15.8 0.8
Fibrous volume (%) 58.0 ± 9.9 56.8 ± 11.0 57.3 ± 10.6 57.6 ± 10.1 1.0
Fibro-lipidic volume (mm3) 7.0 ± 4.9 6.3 ± 4.9 5.8 ± 4.2 7.3 ± 5.0 0.7
Fibro-lipidic volume (%) 13.4 ± 9.1 13.1 ± 9.0 12.3 ± 8.2 13.7 ± 8.7 1.0
Necrotic core volume (mm3) 10.0 ± 6.0 9.2 ± 6.0 9.6 ± 6.2 10.3 ± 6.6 1.0
Necrotic core volume (%) 18.7 ± 9.0 19.2 ± 9.2 19.5 ± 9.0 18.7 ± 9.0 1.0
Calcium volume (mm3) 4.9 ± 3.7 4.9 ± 3.7 5.0 ± 3.7 5.1 ± 3.9 1.0
Calcium volume (%) 9.9 ± 7.7 10.9 ± 8.7 10.8 ± 8.3 9.9 ± 7.9 1.0
Values are normalized to 10 mm segment length and presented as mean ± standard deviation and ANOVA
* Significant difference could be explained by the comparison between center C and D (adjusted P = 0.048 (Holm-Bonferroni
correction), the other comparisons were not significant
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VH-IVUS measurement variability of plaque
composition
VH-IVUS measurements of plaque composition were
highly correlated for the different comparisons. Overall
intra-class correlation and range of the individual
between-center comparisons (within brackets) for (abso-
lute) fibrous, fibro-lipidic, necrotic core and calcified
volume was 0.96 (0.94–0.98), 0.94 (0.91–0.97), 0.98
(0.96–0.99), and 0.99 (0.98–0.99), respectively. There
were significant differences for all plaque components
(Tables 1, 2). The limits of agreement (i.e., 2 SD of mean
difference) forcompositional data werehigher compared
to geometrical data, but similar for the different
comparisons (Fig. 4a, b). Fibrous tissue and necrotic
core showed the highest measurement reproducibility.
Smaller fibrous and fibro-lipidic volumes tended to
show somewhat higher between-center variability.
Discussion
In the present study, we evaluated the between-center
reproducibility of VH-IVUS measurements of target
lesions prior to PCI. VH-IVUS measurements of
plaque and vessel dimensions and plaque composition
were highly correlated for the different comparisons
(overall ICC 0.83–0.99). However, we found signif-
icant between-center differences for vessel dimen-
sions (relative differences of B4%, B12%, B9%, and
B9%; vessel, lumen, and plaque volume and plaque
burden, respectively) and plaque composition (relative
Table 2 Measurement differences of VH-IVUS data from four different centers (A–D)
A versus* B versus* C versus*
B C D C D D
Vessel geometry
D Vessel volume (mm3) 5.9 ± 0.8
P \ 0.01
-0.3 ± 0.5
P = 0.5
3.4 ± 0.5
P \ 0.01
-6.2 ± 0.8
P \ 0.01
-2.5 ± 0.8
P \ 0.01
3.8 ± 0.6
P \ 0.01
D Lumen volume (mm3) -0.6 ± 0.7
P = 0.4
-5.1 ± 0.9
P \ 0.01
3.9 ± 0.7
P \ 0.01
-4.5 ± 0.9
P \ 0.01
4.5 ± 0.8
P \ 0.01
9.0 ± 0.9
P \ 0.01
D Plaquee volume (mm3) 6.5 ± 0.9
P \ 0.01
4.8 ± 0.9
P \ 0.01
-0.5 ± 0.8
P = 0.5
-1.7 ± 1.2
P = 0.2
-7.0 ± 1.2
P \ 0.01
-5.3 ± 0.9
P \ 0.01
D Plaque burden (%) 2.2 ± 0.5
P \ 0.01
3.0 ± 0.5
P \ 0.01
-1.6 ± 0.5
P \ 0.01
0.8 ± 0.6
P = 0.2
-3.8 ± 0.6
P \ 0.01
-4.6 ± 0.5
P \ 0.01
Plaque composition
D Fibrous volume (mm3) 3.0 ± 0.6
P \ 0.01
2.9 ± 0.5
P \ 0.01
-0.7 ± 0.4
P = 0.1
-0.1 ± 0.7
P = 0.9
-3.7 ± 0.7
P \ 0.01
-3.6 ± 0.5
P \ 0.01
D Fibrous volume (%) 1.2 ± 0.3
P \ 0.01
0.7 ± 0.3
P \ 0.01
0.4 ± 0.2
P = 0.02
-0.5 ± 0.2
P = 0.04
-0.8 ± 0.2
P \ 0.01
-0.3 ± 0.2
P = 0.2
D Fibro-lipidic volume (mm3) 0.8 ± 0.2
P \ 0.01
1.2 ± 0.3
P \ 0.01
-0.3 ± 0.2
P = 0.1
0.4 ± 0.2
P = 0.1
-1.0 ± 0.3
P \ 0.01
-1.5 ± 0.2
P \ 0.01
D Fibro-lipidic volume (%) 0.3 ± 0.3
P = 0.3
1.0 ± 0.2
P \ 0.01
-0.3 ± 0.2
P = 0.1
0.7 ± 0.3
P = 0.02
-0.7 ± 0.3
P = 0.05
-1.4 ± 0.2
P \ 0.01
D Necrotic core volume (mm3) 0.7 ± 0.2
P \ 0.01
0.4 ± 0.2
P = 0.02
-0.4 ± 0.2
P = 0.08
-0.3 ± 0.2
P = 0.06
-1.1 ± 0.2
P \ 0.01
-0.8 ± 0.2
P \ 0.01
D Necrotic core volume (%) -0.5 ± 0.2
P = 0.05
-0.8 ± 0.2
P \ 0.01
-0.00 ± 0.2
P = 1.0
-0.3 ± 0.2
P = 0.1
0.5 ± 0.2
P = 0.05
0.8 ± 0.2
P \ 0.01
D Calcium volume (mm3) 0.02 ± 0.1
P = 0.7
-0.1 ± 0.1
P = 0.3
-0.2 ± 0.1
P = 0.03
-0.1 ± 0.1
P = 0.2
-0.2 ± 0.1
P = 0.03
-0.1 ± 0.1
P = 0.2
D Calcium volume (%) -1.0 ± 0.2
P \ 0.01
-1.0 ± 0.2
P \ 0.01
-0.1 ± 0.1
P = 0.6
0.1 ± 0.2
P = 0.7
1.0 ± 0.2
P \ 0.01
0.9 ± 0.2
P \ 0.01
Values are normalized to 10 mm segment length and presented as mean ± standard error of the mean. * Two-sided paired t test
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differences of B15%, B25%, B11%, and B6%;
fibrous, fibro-lipidic, necrotic core, and calcified
plaque components, respectively). The highest mea-
surement reproducibility for plaque components was
found for fibrous tissue and necrotic core.
Rationale of VH-IVUS assessment of coronary
lesions prior to PCI
Percutaneous coronary interventions may cause
microembolization of unstable plaque material, which
can lead to no-reflow phenomenon, myocardial micro-
infarcts with cardiac marker release and impaired left
ventricular function, and significantly impaired clinical
outcome [11, 14, 16, 18, 20]. Several VH-IVUS studies
demonstrated that differences in plaque composition
of target lesions are related to such post-PCI events
[11–19]. Hong et al. showed that relative necrotic core
volumes were significantly larger in patients with
elevated troponin levels following PCI (19.8 ± 10.4%
vs. 12.8 ± 8.4%, P = 0.015) [15]. Bo¨se et al. reported
that cardiac marker release following PCI was much
greater in plaques with a large necrotic core volume
([10.81 mm3; P \ 0.001) with a trend for a lower
increase of cardiac markers in patients treated with
statins before PCI [11]. Certain plaque components or
phenotypes as assessed with VH-IVUS are related to
no-reflow phenomenon post-PCI which may be trig-
gered by such microembolization and adversely
effects prognosis [14, 18]. Hong et al. reported that
relative necrotic core volume serves as an independent
predictor of no-reflow post-stenting in patients with
acute coronary syndrome (odds ratio = 1.126; 95%CI
1.045–1.214, P = 0.002) [14].
Fig. 2 Example of differences in contour detection in a single
frame. The same coronary segment was analyzed by 2 different
centers; please note that differences in contour detection
resulted in differences in plaque composition. Center A
(Greyscale (a) and VH-IVUS (b) analysis) versus Center B
(c and d, resp)
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Therefore, volumetric VH-IVUS assessment of
target lesions prior to PCI may have the potential to
identify lesions at particularly high risk for such
complications and may help to tailor interventions
(i.e., embolic protection device, direct stenting vs.
pre-dilatation etc.) and may help to optimize sys-
temic medical therapy (i.e., therapy with very high
dose statins, or novel anti-atherosclerotic or platelet
inhibiting drugs) [25, 26]. However, only large
multicenter trials will be able to determine the
clinical value of the assessment of plaque composi-
tion with VH-IVUS prior to PCI. An important pre-
requisite for clinical VH-IVUS studies assessing such
relations in advanced coronary lesions, is an adequate
measurement reproducibility of VH-IVUS especially
when pooled IVUS data is used in multicenter trials
or registries [2].
Measurement reproducibility and studies
with multicenter design
Several prior single-center studies demonstrated suf-
ficient reproducibility of VH-IVUS measurements
between observers, catheters, and repeated pullbacks
[2, 8, 9, 21, 23].
Rodriguez-Granillo et al. assessed the measurement
variability of VH-IVUS cross-sectional data obtained
form 16 mild coronary plaques in a single-
center design. The relative intra-observer difference
was \11% for plaque cross-sectional area and
Fig. 3 a Agreement of repeated VH-IVUS measurements of
geometric volumes. Agreement of repeated VH-IVUS mea-
surements of geometry between center A versus B (left), center
A versus C (mid) and center A versus D (right). D = difference.
b Agreement of repeated VH-IVUS measurements of geometric
volumes. Agreement of repeated VH-IVUS measurements of
geometry between center B versus C (left), center B versus
D (mid) and center C versus D (right). D = difference
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compositional measurements showed a variability up
to 24% [9]. Prasad et al. assessed volumetric VH-
IVUS measurement variability of 16 significant cor-
onary plaques (mean plaque burden of 55%) prior to
PCI and reported high agreement for geometrical and
compositional measurements (Spearman’s correlation
[0.8) in a single-center design [8]. A relatively high
intra- and interobserver reproducibility of volumet-
ric geometric and compositional VH-IVUS data
was previously described by Hartmann et al. in a
series of 33 mild-to-moderate diseased coronary
segments [2].
However, the aforementioned studies assessed VH-
IVUS measurement variability of analysts from a single
center or core lab with the same training background. In
a previous multicenter study by this group of investi-
gators, we demonstrated in coronary segments with
mild-to-moderate coronary atherosclerosis a higher
measurement variability and small but significant
measurement differences between analysts from 4
different IVUS centers with different training programs
[21]. In the current study, in much more advanced
atherosclerotic lesions, VH-IVUS measurements of
vessel geometry and plaque composition showed,
despite good correlation between the four IVUS
centers, significant differences for both vessel geometry
and plaque composition. These differences could affect
the results of multicenter trials with VH-IVUS.
Implications for multicenter VH-IVUS studies
of coronary lesions prior to PCI
VH-IVUS measurement differences may have
resulted from systematic over or underestimation of
Fig. 3 continued
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the lumen and/or vessel borders, differences in the
interpolation of the vessel contour at the site of side-
branches or behind calcified areas, and misinterpreta-
tion of thrombus and soft plaque adjacent to the lumen,
which could theoretically have introduced larger
measurement variability. The nature of such advanced
lesions prior to PCI with more calcification, complex
lesions and the IVUS probe against vessel wall/plaque,
may result in increased difficulties of border detection
in contrast with mild-to-moderate diseased coronary
segments. It is likely that small differences or failures
in contour detection will translate into (larger) errors
of measurements of plaque composition. Therefore,
our present study underlines the necessity to analyze
the VH-IVUS data of advanced coronary lesions prior
to PCI at a single site or by an experienced core-lab to
avoid measurement errors and misinterpretation of
acquired data.
Recently, Shin et al. described a simplified contour
detection method for the assessment of plaque com-
position with on VH-IVUS [27]. In Shin’s method the
lumen contour is drawn around the IVUS catheter, that
is, without following the leading edge of the interface
lumen intima. With this method only calcium and
necrotic core can be assessed and related to total vessel
area [27]. Shin et al. were able to demonstrate that
coronary lesions with a greater amount of dense
calcium volume and percent necrotic core to external
Fig. 4 a Agreement of repeated VH-IVUS measurements of
compositional volumes. Agreement of repeated VH-IVUS
measurements of plaque composition between center A versus
B (left), center A versus C (mid) and center A versus D (right). D =
difference. b Agreement of repeated VH-IVUS measurements of
compositional volumes. Agreement of repeated VH-IVUS
measurements of plaque composition between center B versus
C (left), center B versus D (mid) and center C versus D (right).
D = difference
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elastic membrane show more post-PCI myocardial
injury [28]. Nevertheless, exclusive application of this
method is limited by incompleteness of the geomet-
rical and compositional data (e.g., no data on lumen
and plaque size, and no information on fibrous or
fibro-lipidic tissue).
Limitations
The present study was performed in an offline setting
in coronary segments with advanced coronary athero-
sclerosis prior to PCI; therefore, our findings cannot be
extrapolated to VH-IVUS reproducibility studies in an
online setting in the catheterization laboratory or
following stent implantation. Similar to other studies
with IVUS and VH-IVUS, we excluded very tortuous
and severely calcified vessels that could have led to
non-uniform pullbacks and/or inability to detect the
(external) vessel contour [9, 21, 23]. We used the
pcVH software (available in all four centers) to
perform IVUS image analyses in entire coronary
segments. Meanwhile a newer computer software is
available, however, this does not affect the importance
of the present study. The purpose of out present study
was to examine systematic between-center differences
when analyzing lumen and vessel contours with a
semi-automated IVUS analysis program in this spe-
cific set of coronary lesions; it was not our aim to test a
specific software release. In addition, the between-
center differences of the present study were mainly
explained by differences in manual contour editing,
which is still generally not abandoned by the most
recent IVUS analysis software. The variability
between different IVUS catheters or pullback devices,
Fig. 4 continued
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repeated pullbacks, and independent selections of the
segment of interest were not addressed in our present
multicenter study, as this study focused on the
assessment of measurement reproducibility in prede-
fined coronary segments that contained target lesions
prior to PCI.
Conclusions
A central analysis for VH-IVUS multicenter studies of
lesions prior to PCI should be pursued. Moreover, it
may be problematical to pool VH-IVUS data of
individual trials that are analyzed by independent
IVUS centers.
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